M&A - CARILLON SERIES TRUST

Form Type: 497

Filing Date: 2025-04-02

Corporate Action: Merger

Type: Update

Accession Number: 000089843225000225

Filing Summary: The Board of Trustees of Carillon Series Trust has approved a Reorganization Plan for the Carillon Chartwell Small Cap Fund, which will reorganize into the Carillon Chartwell Small Cap Growth Fund. This Reorganization is expected to occur around October 17, 2025, with the Fund continuing to accept purchases and exchanges until October 3, 2025. The Plan involves the transfer of the Fund's assets to the Acquiring Fund and assumes the Fund's liabilities in exchange for shares in the Acquiring Fund, which will be distributed to shareholders in liquidation of the Fund. The transaction is intended to qualify as tax-free for federal income tax purposes, and no shareholder approval is required.

Document Link: View Document

Form Type: RW

Filing Date: 2025-03-19

Corporate Action: Merger

Type: Withdrawal

Accession Number: 000089843225000194

Filing Summary: Carillon Series Trust requests the withdrawal of the amended registration statement on Form N-14 for the Carillon Chartwell Small Cap Growth Fund and Carillon Chartwell Small Cap Fund. The N-14 was filed to register shares of the Acquiring Fund in connection with the reorganization of the Target Fund into the Acquiring Fund. This decision follows discussions with the SEC regarding differences in investment restrictions between the two funds. No shares were issued or sold in connection with the N-14, and the Trust plans to file a new registration statement once the matters are resolved. The request emphasizes alignment with public interest and investor protection.

Document Link: View Document

Form Type: N-14/A

Filing Date: 2025-02-20

Corporate Action: Merger

Type: Update

Accession Number: 000119312525030846

Filing Summary: The document outlines the proposed reorganization (referred to as the 'Reorganization') of the Carillon Chartwell Small Cap Fund (the 'Target Fund') into the Carillon Chartwell Small Cap Growth Fund (the 'Acquiring Fund'). The approval for this reorganization was granted by the Board of Trustees of Carillon Series Trust during a meeting on November 14-15, 2024. It states that no shareholder vote is required due to the governing documents and federal regulations. The Reorganization is set to occur on or about April 25, 2025, whereupon shareholders of the Target Fund will automatically transition to shareholders of the Acquiring Fund, receiving shares of equal value. The rationale behind this merger includes increasing operational efficiency by consolidating similar investment products, maintaining identical investment objectives and strategies, and lowering overall expenses. The document emphasizes that this Reorganization is planned to qualify as tax-free for federal income tax purposes, thereby avoiding additional tax liabilities for shareholders. The detailed workings of the Reorganization, including potential impacts on expenses and how shareholder accounts will be set up, are also discussed in the document, along with the timeline for related actions leading up to the merger.

Document Link: View Document

Form Type: N-14

Filing Date: 2025-01-22

Corporate Action: Merger

Type: New

Accession Number: 000119312525009679

Filing Summary: Carillon Series Trust has filed a Registration Statement under the Securities Act of 1933 for the reorganization of the Carillon Chartwell Small Cap Fund (the Target Fund) into the Carillon Chartwell Small Cap Growth Fund (the Acquiring Fund). This merger will automatically convert shares of the Target Fund into corresponding shares of the Acquiring Fund, which has identical investment objectives and strategies. No shareholder vote or action is required; the reorganization is expected to be effective on or about April 25, 2025. The reorganization is designed to streamline operations and is structured as a tax-free transaction, meaning shareholders of the Target Fund will not recognize any gain or loss for federal income tax purposes as a result of this merger. Shareholders will retain shares of the same class in the new fund with an equal aggregate value to their existing shares. The Board has determined that this move is in the best interest of the shareholders as it consolidates similar investment products and aligns expense ratios. Share purchases in the Target Fund will be allowed until April 16, 2025, after which the Target Fund will cease operation. The costs associated with the reorganization will be borne by the Acquiring Fund, with an expectation of decreasing expenses over time for shareholders. Further information can be obtained by contacting the Carillon Family of Funds or accessing additional documents filed with the SEC.

Document Link: View Document